Protective vaccine-induced CD4+ T cell-independent B cell responses against rabies infection

Journal of Virology

Volumn 86, Issue 21, 2012, Pages 11533-11540

  Dorfmeier, Corin L ^a   Lytle, Andrew G ^a   Dunkel, Amber L ^a   Gatt, Anthony ^a   McGettigana, James P ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; RABIES VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNIZATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RABIES; RABIES VIRUS; SINGLE DRUG DOSE; TREATMENT RESPONSE; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; MICE; MICE, INBRED C57BL; RABIES VACCINES; RABIES VIRUS; VACCINES, ATTENUATED;

MUS; RABIES VIRUS;

EID: 84869044160     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00615-12     Document Type: Article

References (30)

1. Bunschoten H, et al. 1990. Rabies virus cross-reactive murine T cell clones: analysis of helper and delayed-type hypersensitivity function. Viral Immunol. 3:41-53.
2. Cenna J, et al. 2009. Replication-deficient rabies virus-based vaccines aresafe and immunogenic in mice and nonhuman primates. J. Infect. Dis.200:1251-1260.
3. Cenna J, et al. 2008. Immune modulating effect by a phosphoproteindeleted rabies virus vaccine vector expressing two copies of the rabies virus glycoproteins. Vaccine 26:6405- 6414.
4. Erickson LD, et al. 2000. B cell immunopoiesis: visualizing the impact of CD40 engagement on the course of T cell-independent immune responses in an Ig transgenic system. Eur. J. Immunol. 30:3121-3131.
5. Faul EJ, et al. 2010. Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling. PLoS Pathog. 6:e1001016. doi:10.1371/ journa.ppat.1001016.
6. Gavin AL, Barnes N, Dijstelbloem HM, Hogarth PM. 1998. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J. Immunol.160:20 -23.
7. Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R. 2010.Control systems and decision making for antibody production. Nat. Immunol.11:681- 688.
8. Jackson AC. 2011. Update on rabies. Res. Rep. Trop. Med. 2011(2):31- 43.
9. Jackson AC, Wunner W (ed). 2007. Rabies, 2nd ed. Elsevier Academic Press, Amsterdam, Netherlands.
10. Johnson N, Cunningham AF, Fooks AR. 2010. The immune response to rabies virus infection and vaccination. Vaccine 28:3896-3901.
11. Linterman MA, et al. 2010. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 207:353-363.
12. Linterman MA, et al. 2009. Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 206:561-576.
13. Matsumoto T, et al. 2010. Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus.Microbiol. Immunol. 54:673- 683.
14. McGettigan JP. 2011. Experimental rabies vaccines for humans. Exp. Rev.Vaccines 9:1177-1186.
15. McGettigan JP, et al. 2003. Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome. J. Virol. 77:10889 -10899.
16. Mifune K, Takeuchi E, Napiorkowski PA, Yamada A, Sakamoto K.1981. Essential role of T cells in the postexposure prophylaxis of rabies in mice. Microbiol. Immunol. 25:895-904.
17. Minami M, Usui M, Kanno T, Tamura N, Matuhasi T. 1978. Demonstrationof two types of helper T cells for different IgG subclass responses to dinitrophenylated flagellin polymer. J. Immunol. 120:1195-1200.
18. Moore SM, Hanlon CA. 2010. Rabies-specific antibodies: measuring surrogates of protection against a fatal disease. PLoS Negl. Trop. Dis.4:e595. doi:10.1371/journal.pntd.0000595.
19. Morimoto K, et al. 1998. Rabies virus quasispecies: implications for pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 95:3152-3156.
20. O'Connor BP, Gleeson MW, Noelle RJ, Erickson LD. 2003. The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease. Immunol. Rev. 194:61-76.
21. Perry LL, Lodmell DL. 1991. Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus. J. Virol. 65:3429-3434.
22. Plotkin SA. 2008. Vaccines: correlates of vaccine-induced immunity.Clin. Infect. Dis. 47:401- 409.
23. Pone EJ, et al. 2010. Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses. Crit. Rev. Immunol. 30:1-29.
24. Schnell MJ, et al. 2000. Recombinant rabies virus as potential live-viral vaccines for HIV-1. Proc. Natl. Acad. Sci. U.S.A. 97:3544 -3549.
25. Shellito J, et al. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85:1686-1693.
26. Slack J, Der-Balian GP, Nahm M, Davie JM. 1980. Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymusindependent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J. Exp. Med. 151:853- 862.
27. Sze DM, Toellner KM, Garcia de Vinuesa C, Taylor DR, MacLennan IC. 2000. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192:813- 821.
28. Turner GS. 1978. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. J. Gen. Virol. 40:595- 604.
29. Turner GS. 1976. Thymus dependence of rabies vaccine. J. Gen. Virol.33:535-538.
30. WHO. 1997. Recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies. World Health Organization, Geneva, Switzerland.